1. PARP-1 Inhibitors in Oncology The Discovery and Development of CEP-9722, an Orally Active Prodrug for the Treatment of Cancer 2. Rationale for PARP-1 Inhibitors in Oncology…

Slide 1HIGH RESOLUTION OPTICAL COHERENCE TOMOGRAPHY FOR EARLY DETECTION OF EPITHELIAL NEOPLASTIC TRANSFORMATION Asem Ahmed ElFert *, Pankaj Jay Pasricha *, Brent Bell **,…

1. Tumor immunology Integrating Immunity’s Roles in Cancer Suppression and Promotion 1 2. Objectives • Answer the question, how the immune system affects cancer development…

1. FRACP - ENDOCRINOLOGY 2000 FRACP QUESTIONS Question 1 With respect to pregnant women in their 3rd trimester, which of the following is not increased? A) serum cortisol…

1. Ischemic Colitis Marcelyn Coley Team IV Surgery Conference Mount Sinai Hospital 2. Intestinal ischemia Mesenteric ischemia- reduction in intestinal blood supply Acute…

1. Journal of Inorganic Biochemistry 103 (2009) 354–361Contents lists available at ScienceDirect Journal of Inorganic Biochemistryjournal homepage: www.elsevier.com/locate/jinorgbio…

PowerPoint Presentation Colorectal Cancer M. N. Jalalian Medical Intern Tehran University of Medical Sciences Most common malignancy of GI Aging Dominant after age 50 Hereditary…

1. 64Attenuation Patterns in the Abnormal Bowel Wall 2. CLINICAL IMAGAGING AN ATLAS OF DIFFERENTIAL DAIGNOSIS EISENBERG DR. Muhammad Bin Zulfiqar PGR-FCPS III SIMS/SHL 3.…

1. Inflammatory Bowel DiseasesAlka Ingnam 2. Inflammatory bowel disease (IBD)  Refers to two chronic inflammatory GI disorders:  regional enteritis (i.e. crohn's…

Slide 1  Definition : arrest of downward propulsion of intestinal content  Classification : according to : A)pathological cause: 1)simple intestinal obstruction 2)…